elderly lady

Welsh residents receive antiviral Covid tablets

Hundred of Welsh citizens who are at a higher risk of catching Covid-19 have been sent the new antiviral tablets which aim to reduce the severity of Covid symptoms if they were to contract Covid.

The rollout of the tablets, also known as molnupiravir, are part of a clinical trial rand by Oxford University as part of the Panoramic study.

People aged 50 and over and anyone aged 18 and above with underlying health conditions can be part of the study, providing they have a positive Covid-19 test and have had symptoms for less than five days.

Notifications have been sent to anyone who has received a positive PCR test that fits the criteria. The tablets are then delivered to their door within the next 24 hours.

Dr Andrew Carson-Stevens, principal investigator for Wales for the Panoramic study and Health and Care Research Wales speciality lead for primary care, said: "This is such an important development in how we treat and manage Covid-19, especially to those most vulnerable, and I'm so proud that Wales will play an integral part.

"If you fit the study criteria you will be randomised into one of two groups – one to receive the antiviral and standard care and another group which will receive standard care. If you are in the group to receive the new antiviral treatments, you will be sent your medication in the post. Everyone involved will be asked to fill out a daily symptom diary online."

The drug was developed by US drug company Merck and was approved for use in the UK in early November.

Experts believe that the drug will be effective against all strands of the virus and so far, there are no indicators to say that it will be any less effective against Omicron.

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all